Is Kawasaki Disease Caused by a Respiratory Virus?

被引:3
作者
Rand, Kenneth H. [1 ,5 ]
Bhaduri-McIntosh, Sumita [2 ,6 ,7 ]
Gurka, Matthew J. [3 ]
Chi, Xiaofei [3 ]
Harris, Alyssa [4 ]
机构
[1] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA
[2] Univ Florida, Dept Pediat & Mol Genet & Microbiol, Gainesville, FL USA
[3] Univ Florida, Dept Pediat, Gainesville, FL USA
[4] Vizient Inc, Ctr Adv Analyt & Informat, Irving, TX USA
[5] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
[6] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA
[7] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
关键词
respiratory virus positivity rates; Kawasaki disease; COVID lockdown; BioFire syndromic trends;
D O I
10.1097/INF.0000000000003889
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background:Kawasaki disease is characterized by high fever, rash, cervical lymphadenopathy, conjunctival injection, oral mucous membrane changes and swelling of the extremities followed by skin sloughing. Despite >50 years of study, no bacterial, viral or other infectious agent has been consistently associated with the illness. The lockdown and social distancing for COVID-19 in March 2020 led to a marked decrease in respiratory virus circulation. This provided an "experiment of nature" to determine whether Kawasaki disease would decline in parallel. Methods:Discharge ICD-10 diagnosis codes were obtained from the Vizient Clinical Data Base for Kawasaki disease and respiratory viruses, and analyzed for the age group < 5 years. Weekly respiratory virus positivity data were also obtained from BioFire Diagnostics. Results:Common enveloped respiratory viruses declined precipitously from April 2020 through March 2021 to levels at or below historical seasonal minimum levels. Kawasaki Disease declined about 40% compared with 2018-2019, which is distinctly different from the pattern seen for the enveloped respiratory viruses. Strong seasonality was seen for Kawasaki disease as far back as 2010, and correlated most closely with respiratory syncytial virus, human metapneumovirus and less so with influenza virus suggesting there is a baseline level of Kawasaki disease activity that is heightened during yearly respiratory virus activity but that remains at a certain level even in the near total absence of respiratory viruses. Conclusions:The striking decrease in enveloped respiratory viruses after lockdown and social distancing was not paralleled by a comparable decrease in Kawasaki disease incidence, suggesting a different epidemiology.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 18 条
  • [1] Incidence of Kawasaki Disease Before and After the COVID-19 Pandemic in Japan Results of the 26th Nationwide Survey, 2019 to 2020
    Ae, Ryusuke
    Makino, Nobuko
    Kuwabara, Masanari
    Matsubara, Yuri
    Kosami, Koki
    Sasahara, Teppei
    Nakamura, Yosikazu
    [J]. JAMA PEDIATRICS, 2022, 176 (12) : 1217 - 1224
  • [2] Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States
    Burney, Jennifer A.
    Roberts, Samantha C.
    DeHaan, Laurel L.
    Shimizu, Chisato
    Bainto, Emelia, V
    Newburger, Jane W.
    Dominguez, Samuel
    Jone, Pei-Ni
    Jaggi, Preeti
    Szmuszkovicz, Jacqueline R.
    Rowley, Anne H.
    Samuy, Nichole
    Scalici, Paul
    Tremoulet, Adriana H.
    Cayan, Daniel R.
    Burns, Jane C.
    [J]. JAMA NETWORK OPEN, 2022, 5 (06) : E2217436
  • [3] Seasonality of Kawasaki Disease: A Global Perspective
    Burns, Jane C.
    Herzog, Lauren
    Fabri, Olivia
    Tremoulet, Adriana H.
    Rodo, Xavier
    Uehara, Ritei
    Burgner, David
    Bainto, Emelia
    Pierce, David
    Tyree, Mary
    Cayan, Daniel
    [J]. PLOS ONE, 2013, 8 (09):
  • [4] Viral infections associated with Kawasaki disease
    Chang, Luan-Yin
    Lu, Chun-Yi
    Shao, Pei-Lan
    Lee, Ping-Ing
    Lin, Ming-Tai
    Fan, Tsui-Yien
    Cheng, Ai-Ling
    Lee, Wan-Ling
    Hu, Jen-Jan
    Yeh, Shu-Jen
    Chang, Chien-Chih
    Chiang, Bor-Luen
    Wu, Mei-Hwan
    Huang, Li-Min
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (03) : 148 - 154
  • [5] Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan
    Hara, Takuya
    Furuno, Kenji
    Yamamura, Kenichiro
    Kishimoto, Junji
    Mizuno, Yumi
    Murata, Kenji
    Onoyama, Sagano
    Hatae, Ken
    Takemoto, Megumi
    Ishizaki, Yoshito
    Kanno, Shunsuke
    Sato, Kazuo
    Motomura, Yoshitomo
    Sakai, Yasunari
    Ohga, Shouichi
    Yashiro, Mayumi
    Nakamura, Yoshikazu
    Hara, Toshiro
    [J]. JAMA NETWORK OPEN, 2021, 4 (04) : e214475
  • [6] Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan
    Iio, Kyohei
    Matsubara, Kousaku
    Miyakoshi, Chisato
    Ota, Kunitaka
    Yamaoka, Rika
    Eguchi, Junji
    Matsumura, Osamu
    Okutani, Takahiro
    Ueda, Ikuyo
    Nishiyama, Masahiro
    [J]. BMJ PAEDIATRICS OPEN, 2021, 5 (01)
  • [7] Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era A Nationwide Observational Study in Korea
    Kang, Ji-Man
    Kim, Young-Eun
    Huh, Kyungmin
    Hong, Jinwook
    Kim, Dong Wook
    Kim, Min Young
    Jung, Se Yong
    Kim, Jong-Hun
    Jung, Jaehun
    Ahn, Jong Gyun
    [J]. CIRCULATION, 2021, 143 (25) : 2508 - 2510
  • [8] Seasonal Trends of Viral Prevalence and Incidence of Kawasaki Disease: A Korea Public Health Data Analysis
    Lim, Jae Hee
    Kim, Yu Kyeong
    Min, So Hyeon
    Kim, Sang Won
    Lee, Young Hwan
    Lee, Jae Min
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [9] Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative
    Martin, Blake
    DeWitt, Peter E.
    Russell, Seth
    Anand, Adit
    Bradwell, Katie R.
    Bremer, Carolyn
    Gabriel, Davera
    Girvin, Andrew T.
    Hajagos, Janos G.
    McMurry, Julie A.
    Neumann, Andrew J.
    Pfaff, Emily R.
    Walden, Anita
    Wooldridge, Jacob T.
    Yoo, Yun Jae
    Saltz, Joel
    Gersing, Ken R.
    Chute, Christopher G.
    Haendel, Melissa A.
    Moffitt, Richard
    Bennett, Tellen D.
    [J]. JAMA NETWORK OPEN, 2022, 5 (02)
  • [10] Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding
    Munywoki, P. K.
    Koech, D. C.
    Agoti, C. N.
    Kibirige, N.
    Kipkoech, J.
    Cane, P. A.
    Medley, G. F.
    Nokes, D. J.
    [J]. EPIDEMIOLOGY AND INFECTION, 2015, 143 (04) : 804 - 812